Denali Therapeutics Inc.

NASDAQ: DNLI
Share price (8/15/25): $14.70
Market cap (8/15/25): $2.149 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Indentures Filter

from S-3ASR 45 pages Denali Therapeutics Inc. Indenture Dated as of , 20 [ ] Trustee

from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

from 10-Q 13 pages Form of Pre-Funded Warrant to Purchase Common Stock

from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

from 8-K 12 pages Form of Pre-Funded Warrant to Purchase Common Stock

from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

from S-3ASR 45 pages Denali Therapeutics Inc. Indenture Dated as of , 20 [ ] Trustee

from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

from S-1/A 2 pages Indenture or similar

from S-1 157 pages Investors’ Rights Agreement

from DRS 157 pages Investors’ Rights Agreement